Show
Sort by
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases : insights after the first 5 years of the ERN ReCONNET
-
The impact of COVID-19 on rare and complex connective tissue diseases : the experience of ERN ReCONNET
-
- Journal Article
- A1
- open access
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update